2
Total Mentions
2
Documents
14
Connected Entities
Organization referenced in documents
EFTA00689626
wet AMD patients who have a need for frequent injections." Avalanche plans a study on the effectiveness of AVA-101 in the second half of this year, Chalberg said. Wet AMD affects 150,000 people in the U.S., according to Avalanche. It typically occurs with aging patients when fluid from blood vessels lea
EFTA01368453
wet AMD patients who have a need for frequent injections." Avalanche plans a study on the effectiveness of AVA-101 in the second half of this year, Chalberg said. Wet AMD affects 150,000 people in the U.S., according to Avalanche. It typically occurs with aging patients when fluid from blood vessels lea

Roche
OrganizationPharmaceutical company
Regeneron
PersonSurname reference in documents

Bloomberg L.P.
OrganizationAmerican privately held financial, software, data, and media company
Regeneron Pharmaceuticals Inc.
OrganizationOrganization referenced in documents
Avalanche Drops
PersonName reference in documents
Danielle Burger
PersonName reference in documents
Gbola Amusa
PersonName reference in documents
Gary Putka
PersonName reference in documents
Avalanche Biotechnologies Inc.
OrganizationOrganization referenced in documents
AVA-101
OrganizationOrganization referenced in documents
Roche Holding AG's
OrganizationOrganization referenced in documents
Lucentis
OrganizationOrganization referenced in documents
Chardan Capital Markets
OrganizationOrganization referenced in documents
Avalanche
OrganizationOrganization referenced in documents